Baudax Bio (BXRXQ) S-3 Shelf registration

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Baudax Bio, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered(1)

Proposed Maximum Offering Price Per Unit(2)

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to Be Paid

Equity

Common Stock, $0.01 par value per share

Other(2)

785,402

$0.52(2)

$408,409.04

.00011020

$45.01

Carry Forward Securities

Carry Forward Securities

Total Offering Amounts

$408,409.04

$45.01

Total Fees Previously Paid

$0.00

Total Fee Offsets

$0.00

Net Fee Due

$45.01

(1) The Registrant is hereby registering for resale from time to time by the selling stockholder named herein of up to 785,402 shares of its common stock issuable upon the exercise of certain warrants, issued to the selling stockholder in May 2020 and March 2023. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers an indeterminate number of shares of common stock that may be issued as a result of stock splits, stock dividends, or similar transactions.

(2) Estimated in accordance with Rule 457(c) under the Securities Act solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the registrant’s common shares, as reported on the Nasdaq Capital Market on June 23, 2023, a date within five business days prior to the initial filing of this registration statement on June 28, 2023.